Pandemics and Overdoses: COVID-19 May Worsen Our Opioid Epidemic

The novel coronavirus has decimated our economy at the same time as it has directly threatened our health. As if that weren’t bad enough, the economic damage Covid-19 is causing could have an indirect impact on our health. Consider what we already know about economic downturns and opioid overdoses. A research team led by Atheendar […]

Read More
Critics Wonder Whether the FDA Is Too Slow to Handle a Pandemic

The FDA plays a critical role in our nation’s response to the COVID-19 pandemic. It helps decide which medicines are safe and effective to treat the disease. It evaluates the accuracy and reliability of laboratory tests. And it will play a central role in assessing potential vaccines. But will the FDA bureaucracy move with the […]

Read More
Science Isn’t Meant To Be Followed

Science cannot lead us out of this pandemic. Whatever paths we take to navigate COVID-19 need to be chosen through political processes. The true role of science is to illuminate these pathways, guiding our policy choices by showing us what’s at stake.

Read More
Antibody Tests Could Offer A False Sense of Security

A lot of hope on reopening businesses and returning to work in the U.S. hinges on COVID-19 testing and the development of treatments and a vaccine. But as the country ramps up antibody testing – analyzing blood samples for signs someone has been exposed to or infected with the coronavirus that causes COVID-19 – physician […]

Read More
Expert: NC better positioned than other states to respond to pandemic (WRAL)

The slow growth in coronavirus cases in North Carolina relative to New York and some other states puts North Carolina in better position to respond to the pandemic, according to a Duke University professor. Economist Mark McClellan, the director of the Duke-Margolis Center for Health Policy, was U.S. Food and Drug Administration commissioner during the […]

Read More
Here’s Why Pharmaceutical Companies Raise Their Prices So Much

Yes, I’ve ranted about healthcare prices before. On more than one occasion. But I have a new rant for you. It’s not about the high price of new drugs It’s not about a couple pharmo-bro CEOs hiking prices of generic medications by 4 or 5,000% It’s about brand name drugs already on the market, that, […]

Read More

PeterUbel